<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001763581</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001668243</issuerCik>
      <issuerName>UroGen Pharma Ltd.</issuerName>
      <secFileNumber>001-38079</secFileNumber>
      <issuerAddress>
        <com:street1>9 HA'TA'ASIYA ST</com:street1>
        <com:city>RA'ANANA</com:city>
        <com:stateOrCountry>L3</com:stateOrCountry>
        <com:zipCode>4365007</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>972 9 770 7601</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Schoenberg Mark</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>RBC CAPITAL MARKETS LLC</name>
        <address>
          <com:street1>250 NICOLLET MALL, SUITE 1700</com:street1>
          <com:city>MINNEAPOLIS</com:city>
          <com:stateOrCountry>MN</com:stateOrCountry>
          <com:zipCode>55401</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>60677</noOfUnitsSold>
      <aggregateMarketValue>2892242.00</aggregateMarketValue>
      <noOfUnitsOutstanding>48880564</noOfUnitsOutstanding>
      <approxSaleDate>08/20/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>01/27/2023</acquiredDate>
      <natureOfAcquisitionTransaction>STOCK OPTION EXERCISE</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>60677</amountOfSecuritiesAcquired>
      <paymentDate>01/27/2023</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>MARK SCHOENBERG C/O RBC CAPITAL MARKETS LLC</name>
        <address>
          <com:street1>250 NICOLLET MALL</com:street1>
          <com:city>MINNEAPOLIS</com:city>
          <com:stateOrCountry>MN</com:stateOrCountry>
          <com:zipCode>55401</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>UROGEN PHARMA LTD </securitiesClassTitle>
      <saleDate>07/09/2026</saleDate>
      <amountOfSecuritiesSold>10000</amountOfSecuritiesSold>
      <grossProceeds>400008.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>MARK SCHOENBERG C/O RBC CAPITAL MARKETS LLC</name>
        <address>
          <com:street1>250 NICOLLET MALL</com:street1>
          <com:city>MINNEAPOLIS</com:city>
          <com:stateOrCountry>MN</com:stateOrCountry>
          <com:zipCode>55401</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>UROGEN PHARMA LTD</securitiesClassTitle>
      <saleDate>06/22/2026</saleDate>
      <amountOfSecuritiesSold>10000</amountOfSecuritiesSold>
      <grossProceeds>350143.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>08/20/2026</noticeDate>
      <signature>POA / JEFFREY EISCHENS</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
